These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The effect of exhalation flow on endogenous particle emission and phospholipid composition. Larsson P; Bake B; Wallin A; Hammar O; Almstrand AC; Lärstad M; Ljungström E; Mirgorodskaya E; Olin AC Respir Physiol Neurobiol; 2017 Sep; 243():39-46. PubMed ID: 28502893 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Sandström T; Bjermer L; Rylander R Eur Respir J; 1992 Sep; 5(8):992-6. PubMed ID: 1426208 [TBL] [Abstract][Full Text] [Related]
10. Surfactant protein A and albumin in particles in exhaled air. Larsson P; Mirgorodskaya E; Samuelsson L; Bake B; Almstrand AC; Bredberg A; Olin AC Respir Med; 2012 Feb; 106(2):197-204. PubMed ID: 22100538 [TBL] [Abstract][Full Text] [Related]
11. Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge. Mole S; Harry A; Fowler A; Hotee S; Warburton J; Waite S; Beerahee M; Behm DJ; Badorrek P; Müller M; Faulenbach C; Lazaar AL; Hohlfeld JM Pulm Pharmacol Ther; 2020 Oct; 64():101977. PubMed ID: 33189900 [TBL] [Abstract][Full Text] [Related]
12. Surfactant Protein A in particles in exhaled air (PExA), bronchial lavage and bronchial wash - a methodological comparison. Behndig AF; Mirgorodskaya E; Blomberg A; Olin AC Respir Res; 2019 Sep; 20(1):214. PubMed ID: 31558154 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic characterization of the human segmental endotoxin challenge model. Gress C; Litzenburger T; Schmid R; Xiao K; Heissig F; Muller M; Gupta A; Hohlfeld JM Sci Rep; 2024 Jan; 14(1):1721. PubMed ID: 38242945 [TBL] [Abstract][Full Text] [Related]
14. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers. Holz O; Tan L; Schaumann F; Müller M; Scholl D; Hidi R; McLeod A; Krug N; Hohlfeld JM Pulm Pharmacol Ther; 2015 Dec; 35():50-9. PubMed ID: 26545873 [TBL] [Abstract][Full Text] [Related]
15. Differences in surfactant lipids collected from pleural and pulmonary lining fluids. Mills PC; Chen Y; Hills YC; Hills BA Pharm Res; 2005 Nov; 22(11):1926-30. PubMed ID: 16132340 [TBL] [Abstract][Full Text] [Related]
16. Current smoking alters phospholipid- and surfactant protein A levels in small airway lining fluid: An explorative study on exhaled breath. Viklund E; Bake B; Hussain-Alkhateeb L; Koca Akdeva H; Larsson P; Olin AC PLoS One; 2021; 16(6):e0253825. PubMed ID: 34170967 [TBL] [Abstract][Full Text] [Related]
17. Surfactant protein A in particles in exhaled air and plasma. Koca H; Farbrot A; Olin AC; Emilsson ÖI Respir Physiol Neurobiol; 2022 Jul; 301():103899. PubMed ID: 35364290 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Dargaville PA; South M; McDougall PN Am J Respir Crit Care Med; 1999 Sep; 160(3):771-7. PubMed ID: 10471595 [TBL] [Abstract][Full Text] [Related]
19. [Influence of inhaled nitric oxide on surfactant in the total cardiopulmonary bypass pig model]. Wang T; Yang B; Blaise GA Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):544-8. PubMed ID: 14601318 [TBL] [Abstract][Full Text] [Related]
20. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice. Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]